Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, 09 1997, 607-610, Vol 4, No. 5
F Nicoletti, G Mancuso, FA Ciliberti, C Beninati, M Carbone, S Franco and V Cusumano
The lethal effects occurring in neonatal (<24-h-old) BALB/c mice after
challenge with 25 mg of lipopolysaccharide (LPS) per kg of body weight were
significantly counteracted by pretreatment with recombinant interleukin-10
(rIL-10; 25 or 50 ng/mouse). Concordantly, blockage of endogenous IL-10
with the SXC1 monoclonal antibody increased LPS- induced mortality. Both
IL-10 and SXC1 modulated the release of tumor necrosis factor alpha
(TNF-alpha) so that, relative to controls, peak TNF-alpha values after LPS
challenge were decreased by rIL-10 and increased by anti-IL-10.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Endotoxin-induced lethality in neonatal mice is counteracted by interleukin-10 (IL-10) and exacerbated by anti-IL-10
Institute of Microbiology, University of Milan, Italy.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |